Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joyce Wing Yan Chan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Role of Endobronchial Navigation in Lung Cancer Management

    by Aliss Tsz Ching Chang, Joyce Wing Yan Chan, Rainbow Wing Hung Lau, Junko Ching Shun Chan, Wei Liu, Calvin Sze Hang Ng

    The landscape of lung cancer management is undergoing a transformative paradigm shift, shifting from the traditional focus on solitary tumors to the recognition and treatment of small, multifocal, ground-glass lesions—a change driven predominantly by the widespread adoption of low-dose computed tomography screening. These multifocal tumors pose unprecedented diagnostic and therapeutic challenges due to their minute size, often subsolid consistency, and complex distribution within the lung. To address these complexities, pioneering technological innovations have emerged to enhance lesion localization accuracy and elevate treatment precision. Among these, the advent of advanced navigation bronchoscopy stands out as a groundbreaking development, revolutionizing both diagnostic workflows and local ablation strategies, thereby fundamentally redefining the management of multifocal lung tumors. This approach has yielded remarkable clinical outcomes, characterized by superior efficacy and a highly favorable safety profile. Further elevating this field are integrations of robotic-assisted bronchoscopy, hybrid operating room, and artificial intelligence—collectively constituting a comprehensive, streamlined treatment pathway that aims to deliver a cohesive, minimally invasive, one-stop solution for lung cancer therapy. As these technologies continue to evolve, an array of innovative bronchoscopy systems and ablative modalities remain at the forefront of ongoing research and development. In this chapter, we will explore the transformative role of navigation bronchoscopy in lung cancer management, critically examine the latest technological breakthroughs, and project future directions poised to redefine therapeutic standards in this rapidly evolving domain.

  • Open Access

    Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?

    by Joyce W. Y. Chan, Ivan C. H. Siu, Aliss T. C. Chang, Molly S. C. Li, Rainbow W. H. Lau, Tony S. K. Mok, Calvin S. H. Ng

    The demand for parenchyma-sparing local therapies for lung cancer is rising owing to an increasing incidence of multifocal lung cancers and patients who are unfit for surgery. With the latest evidence of the efficacy of lung cancer screening, more premalignant or early-stage lung cancers are being discovered and the paradigm has shifted from treatment to prevention. Transbronchial therapy is an important armamentarium in the local treatment of lung cancers, with microwave ablation being the most promising based on early to midterm results. Adjuncts to improve transbronchial ablation efficiency and accuracy include mobile C-arm platforms, software to correct for the CT-to-body divergence, metal-containing nanoparticles, and robotic bronchoscopy. Other forms of energy including steam vapor therapy and pulse electric field are under intensive investigation.


  • Open Access

    Image-Guided Ablative Therapies for Lung Tumors

    by Joyce W.Y. Chan, Rainbow W.H. Lau, Calvin S.H. Ng

    While the gold standard for early stage lung cancers is still surgical resection, many patients have comorbidities or suboptimal lung function making surgery unfavorable. At the same time, more and more small lung nodules are being incidentally discovered on computer tomography (CT), leading to the discovery of pre-malignant or very early stage lung cancers without regional spread, which could probably be eradicated without anatomical surgical resection. Various ablative energies and technologies are available on the market, including radiofrequency ablation, microwave ablation, cryoablation, and less commonly laser ablation and irreversible electroporation. For each technology, the mechanism of action, advantages, limitations, potential complications and evidence-based outcomes will be reviewed. Traditionally, these ablative therapies were done under CT guidance with percutaneous insertion of ablative probes. Recently, bronchoscopic ablation under ultrasound, CT, or electromagnetic navigation bronchoscopy guidance is gaining popularity due to improved navigation precision, reduced pleural-based complications, and providing a true “wound-less” option.